Guardant Health
GH
#1020
Rank
A$33.63 B
Marketcap
A$250.66
Share price
-0.48%
Change (1 day)
176.47%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company